MIRAVANT MEDICAL TECHNOLOGIES has a total of 11 patent applications. Its first patent ever was published in 1999. It filed its patents most often in Canada, EPO (European Patent Office) and Australia. Its main competitors in its focus markets medical technology, pharmaceuticals and optics are PILL PHARMA LTD E, TANKOVICH NIKOLAI and NANOSPECTRA BIOSCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | United States | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals | |
#3 | Optics | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Electrotherapy | |
#2 | Diagnosis and surgery | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Optical systems | |
#6 | Measuring light |
# | Name | Total Patents |
---|---|---|
#1 | Hill John S | 8 |
#2 | Walker Jeffrey P | 6 |
#3 | Rychnovsky Steven John | 5 |
#4 | Vasek Jeffrey A | 4 |
#5 | Franco John A | 4 |
#6 | Waters Christina Ann | 3 |
#7 | Stephens W Patrick | 3 |
#8 | Nielsen Heidi | 3 |
#9 | Rychnovsky Steven J | 2 |
#10 | Leitch Ian M | 2 |
Publication | Filing date | Title |
---|---|---|
CA2495562A1 | Light delivery catheter | |
EP1526801A2 | Catheter for diagnosis and treatment of diseased vessels | |
US6783541B2 | Methods for inhibiting or suppressing stenosis of arteriovenous access fistulas and grafts | |
EP1251828A1 | Local drug delivery using photosensitizer-mediated and electromagnetic radiation-enhanced vascular permeability | |
US6138046A | Dosimetry probe |